ArticleACS applied materials & interfaces2026
Engineered Energy-Harvesting Hybrid Nanoscintillators for Enhanced Cancer Radiotherapy.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During treatment, ionizing radiation interacts with biological tissues, generating high-energy charges that diffuse through the medium, damaging cellular DNA, or inducing the formation of cytotoxic reactive oxygen species (ROS) via water radiolysis. To enhance and localize ROS production by improving the interaction with ionizing radiation and optimizing the harvesting and utilization of deposited energy, we designed and developed a multicomponent nanomaterial as a prototype for the creation of coadjutant agents aimed at improving the efficacy and safety of radiotherapy. The system consists of a dense biocompatible magnesium silicate nanotube core, which enhances interaction with ionizing radiation, decorated with a dual layer of conjugated photosensitizers for singlet oxygen and ROS generation. Thanks to this optimized architecture that boosts the harvesting of the energy deposited by the ionizing radiation, exposure to X-rays resulted in a dramatic increase of almost 2 orders of magnitude in singlet oxygen generation yield compared to previously studied systems. This was accompanied by an excellent glioblastoma cell-killing efficiency at low concentrations, thus, strongly supporting the proposed nanomaterial architecture as a model for the development of next-generation radiotherapy coadjutants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.